Cardiovascular Surgical Devices and Technologies

Cardiovascular Surgical Devices and Technologies Market Outlook

The global cardiovascular surgical devices and technologies market is anticipated to reach USD 53.67 billion by 2025, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2035. This growth is primarily attributed to the rising prevalence of cardiovascular diseases, advancements in surgical technology, and an increasing geriatric population. In addition, the integration of artificial intelligence and robotics in surgical procedures is significantly enhancing the precision and efficiency of cardiovascular surgeries. Furthermore, the increasing awareness regarding early diagnosis and treatment options for cardiovascular ailments is driving the demand for advanced surgical devices and technologies. The emergence of innovative products and solutions designed to improve patient outcomes is also expected to fuel market growth over the coming years.

Growth Factor of the Market

Several factors contribute to the robust growth of the cardiovascular surgical devices and technologies market. One of the primary drivers is the increasing incidence of cardiovascular diseases globally, which necessitates surgical interventions. The rise in sedentary lifestyles, unhealthy dietary habits, and the growing prevalence of obesity and diabetes are contributing to an upsurge in cardiovascular conditions. Moreover, advancements in technology, such as minimally invasive surgical techniques and improved imaging technologies, are making cardiovascular surgeries safer and more efficient, thereby increasing their adoption rates. The growing aging population is another significant contributor, as older individuals are more susceptible to heart-related issues, leading to higher demands for surgical devices. In addition, government initiatives and funding for healthcare infrastructure development are improving access to surgical interventions, further propelling market growth.

Key Highlights of the Market

• The market is projected to witness a CAGR of 6.8% from 2025 to 2035.
• Cardiac Ablation Devices and Heart Valves are among the fastest-growing product types.
• The increasing prevalence of arrhythmias is driving the demand for cardiovascular monitoring devices.
• North America holds the largest market share due to advanced healthcare infrastructure and high healthcare expenditure.
• Technological advancements and the introduction of robotic-assisted surgery are transforming surgical practices.

By Product Type

Cardiac Ablation Devices:

Cardiac ablation devices are crucial in treating arrhythmias and other heart rhythm disorders. These devices utilize targeted energy to ablate (destroy) tissue that may be causing abnormal electrical signals in the heart. The growth in this segment is largely driven by the increasing incidence of atrial fibrillation and other arrhythmias. Additionally, technological advancements such as improved catheter designs and the integration of real-time imaging systems have enhanced the effectiveness of ablation procedures, leading to improved patient outcomes. With the rise in demand for these procedures, manufacturers are focusing on developing innovative solutions that offer better performance and safety, further driving growth in the cardiac ablation devices market.

Cardiopulmonary Bypass Equipment:

Cardiopulmonary bypass equipment is essential during open-heart surgeries, as it temporarily takes over the function of the heart and lungs. The market for this equipment is expanding due to the increasing number of cardiac surgeries and a growing understanding of the benefits of such interventions. Innovations in technology, including miniature pumps and oxygenators, are improving the efficiency and reducing the risks associated with cardiopulmonary bypass procedures. Additionally, the development of advanced biocompatible materials is enhancing patient safety by reducing the risk of complications related to the use of bypass equipment, thereby propelling the market further.

Cardiovascular Monitoring Devices:

The cardiovascular monitoring devices segment is experiencing significant growth due to the increasing need for continuous monitoring of patients with cardiovascular conditions. These devices allow for real-time tracking of heart activity and can alert healthcare providers to potential issues, facilitating timely interventions. With the rising prevalence of coronary artery disease and heart failure, the demand for effective monitoring solutions is on the rise. Innovations in wearable technology and remote monitoring systems are further enhancing the market, providing patients and healthcare professionals with better accessibility and control over heart health. This trend is expected to continue as healthcare systems increasingly adopt telemedicine and remote patient monitoring solutions.

Cardiac Assist Devices:

Cardiac assist devices, such as ventricular assist devices (VADs) and intra-aortic balloon pumps, play a crucial role in supporting patients with severe heart conditions. The market for these devices is growing significantly due to the increasing incidence of heart failure and the rising number of patients awaiting heart transplants. Technological advancements, including miniaturization and the development of more efficient devices, are enhancing the usability and effectiveness of cardiac assist technologies. Furthermore, the growing awareness of heart health and the need for advanced treatment options are driving the demand for these devices, positioning them as essential tools in the management of severe cardiac conditions.

Heart Valves:

The heart valves market is driven by the rising prevalence of valvular heart diseases, which are increasingly being diagnosed and treated with surgical interventions. The development of innovative valve technologies, such as transcatheter aortic valve replacement (TAVR) and tissue-engineered valves, is contributing to market growth. These advancements allow for less invasive procedures and better patient outcomes, which are highly appealing to both patients and healthcare providers. The growing number of elderly individuals, who are more prone to heart valve disorders, further bolsters the market for heart valves, as this demographic increasingly seeks effective treatment options for their cardiovascular issues.

By Application

Coronary Artery Disease:

The application of cardiovascular surgical devices in treating coronary artery disease (CAD) is a significant segment of the market, accounting for a considerable share of the overall industry. CAD is one of the leading causes of morbidity and mortality worldwide, necessitating effective surgical interventions. The demand for devices used in procedures such as angioplasty and stent placement is rising due to the high prevalence of CAD. Additionally, advancements in stent technology, including bioresorbable stents, are enhancing the effectiveness of treatment and reducing complications, further driving market growth in this segment. As awareness regarding heart health increases, more patients are seeking surgical options, contributing to the expansion of the market.

Heart Failure:

The heart failure application segment is witnessing substantial growth due to the rising incidence of this condition, which has become a significant public health concern globally. Heart failure often leads to multiple hospitalizations and a high burden on healthcare systems, necessitating the use of advanced surgical devices and technologies. Devices such as implantable cardioverter-defibrillators (ICDs) and ventricular assist devices are gaining traction as effective treatment options for heart failure patients. The focus on improving patient quality of life and outcomes is driving innovation and development within this segment. Furthermore, the increasing number of patients living with heart failure underscores the importance of advanced surgical solutions in managing this chronic condition.

Arrhythmias:

Arrhythmias are a common cardiac condition characterized by irregular heartbeats, leading to serious health risks if left untreated. The market for cardiovascular surgical devices in this application is growing rapidly, driven by increasing awareness and advancements in treatment options such as cardiac ablation and implantable devices. As the number of patients diagnosed with arrhythmias continues to rise, the demand for effective surgical interventions and monitoring devices is expanding significantly. Innovations in technology, including the development of catheter-based techniques and improved mapping systems, are enhancing the precision and effectiveness of treatments, contributing to market growth in this area.

Peripheral Artery Disease:

Peripheral artery disease (PAD) affects millions of individuals worldwide and is associated with significant morbidity. The application of cardiovascular surgical devices in treating PAD involves techniques such as angioplasty and stenting to restore blood flow to the limbs. The increasing prevalence of PAD, coupled with rising awareness about its associated risks, is driving demand for effective treatment options. The development of advanced stent technologies and minimally invasive procedures is improving outcomes for patients and expanding treatment options for healthcare providers. As healthcare systems focus on improving patient outcomes, the market for devices used in the treatment of PAD is expected to grow significantly.

By Distribution Channel

Hospitals:

Hospitals represent the largest distribution channel for cardiovascular surgical devices, accounting for a significant share of the market. The increased number of surgical procedures performed in hospitals, such as open-heart surgeries and minimally invasive interventions, drives the demand for surgical devices and technologies. Hospitals are equipped with advanced surgical facilities and highly trained professionals, ensuring that patients receive comprehensive care. Additionally, the trend toward integrated healthcare systems is facilitating collaboration between hospitals and device manufacturers, further enhancing the distribution of these devices. With the growing prevalence of cardiovascular diseases, hospitals will continue to be a critical channel for the delivery of surgical solutions.

Specialty Clinics:

Specialty clinics are emerging as a significant distribution channel for cardiovascular surgical devices, as they focus on specific healthcare services related to heart conditions. These clinics often provide specialized care for patients with cardiovascular diseases, enhancing the accessibility of advanced surgical options. The growth of specialty clinics is driven by the increasing number of patients seeking targeted care, as well as advancements in technology that allow for outpatient procedures. Furthermore, the collaboration between specialty clinics and hospitals is enhancing patient access to surgical interventions, allowing for better management of heart-related conditions. As these clinics continue to grow, they will play a vital role in the distribution of cardiovascular surgical devices.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining popularity as an alternative distribution channel for cardiovascular surgical devices. These centers focus on providing outpatient surgical procedures, which are often less invasive and require shorter recovery times. The trend toward outpatient care is driven by rising patient preferences for convenience and reduced healthcare costs. ASCs are increasingly equipped with advanced surgical technologies, allowing for the performance of complex procedures that were previously limited to hospitals. As the demand for outpatient surgical options continues to grow, ASCs will play a critical role in the distribution and utilization of cardiovascular surgical devices.

By Ingredient Type

Stents:

Stents are widely used in cardiovascular surgeries, particularly in treating coronary artery disease through angioplasty procedures. The demand for stents is driven by the increasing prevalence of coronary artery disease and the necessity for effective treatments to restore blood flow. The introduction of innovative stent designs, such as drug-eluting stents, has significantly improved patient outcomes and reduced the risk of restenosis. These advancements are propelling the market for stents, as healthcare providers continually seek better solutions for their patients. As more patients are diagnosed with cardiovascular conditions, the demand for stenting procedures will continue to rise, further driving market growth.

Grafts:

Grafts are critical components in various cardiovascular surgical procedures, particularly in bypass surgeries. They provide a means to redirect blood flow around blocked arteries, thereby restoring circulation. The market for grafts is growing due to the increasing incidence of coronary artery disease and peripheral artery disease. Innovations in graft technology, including the development of biocompatible materials and better manufacturing processes, are enhancing the effectiveness of these devices. Furthermore, the growing number of surgical interventions aimed at treating vascular diseases is propelling the demand for grafts, making them a significant segment within the cardiovascular surgical devices market.

Catheters:

Catheters play a vital role in various cardiovascular procedures, including diagnostics and treatment interventions. The market for catheters is expanding due to the increasing number of cardiac procedures performed annually, such as catheterization and ablation. Advancements in catheter technology, including improved materials and designs, are enhancing their performance and safety. The growing emphasis on minimally invasive procedures is also contributing to the demand for catheters, as they allow for better precision and quicker recovery times for patients. As healthcare providers continue to adopt advanced catheter technologies, the demand within this segment will likely grow significantly.

Pacemakers:

Pacemakers are essential devices used to regulate heartbeats in patients with arrhythmias or heart block. The growing prevalence of these conditions is driving the demand for pacemakers, making them a critical component of the cardiovascular surgical devices market. Technological advancements, such as the development of leadless pacemakers and MRI-compatible devices, are enhancing patient experiences and outcomes. As more individuals are diagnosed with heart rhythm disorders, the need for effective pacing solutions will continue to rise. Additionally, the growing awareness of heart health and the importance of early intervention are further propelling the market for pacemakers.

Defibrillators:

Defibrillators are crucial medical devices used to restore normal heart rhythms in patients experiencing sudden cardiac arrest or life-threatening arrhythmias. The market for defibrillators is witnessing growth due to the increasing incidence of cardiovascular diseases and the growing awareness of sudden cardiac arrest. Innovations in defibrillator technology, including automated external defibrillators (AEDs) and wearable defibrillators, are making these life-saving devices more accessible to the general population. The emphasis on public access to defibrillation and the establishment of programs to equip public spaces with AEDs are further driving the demand for these devices. As awareness and education around sudden cardiac events increase, the market for defibrillators will continue to expand.

By Region

The cardiovascular surgical devices and technologies market is experiencing significant growth across various regions, with North America holding the largest share. The region benefits from a well-established healthcare infrastructure, high healthcare expenditure, and advanced technological adoption. The North American market is projected to grow at a CAGR of 6.5% from 2025 to 2035, driven by the increasing prevalence of cardiovascular diseases, rising awareness of heart health, and technological advancements in surgical procedures. The United States and Canada are leading contributors to this growth, as they continue to invest in research and development to create innovative cardiovascular solutions.

Europe is also witnessing substantial growth in the cardiovascular surgical devices market, fueled by the rising incidence of cardiovascular diseases and a growing aging population. The European market is expected to grow steadily, with significant contributions from countries such as Germany, France, and the United Kingdom. Increased investment in healthcare and technology, along with government initiatives aimed at improving patient outcomes, are driving demand in this region. Meanwhile, the Asia Pacific region is quickly emerging as a lucrative market, with a projected growth rate exceeding 7.0% during the forecast period, driven by increasing healthcare access, rising disposable incomes, and a growing focus on healthcare infrastructure development. As the market continues to evolve, regions like Latin America and the Middle East and Africa will also emerge, albeit at a slower pace, due to varying levels of healthcare access and investment.

Opportunities

The cardiovascular surgical devices market presents numerous opportunities for growth, especially in emerging economies. As healthcare infrastructure continues to improve in countries across Asia, Latin America, and the Middle East, there is an increasing demand for advanced surgical devices. This is particularly true in regions that are witnessing a rise in the prevalence of lifestyle-related cardiovascular diseases. By investing in localized manufacturing and distribution channels, companies can capitalize on the growing demand for affordable and effective cardiovascular solutions tailored to the needs of these markets. Furthermore, partnerships with local healthcare providers can facilitate quicker market penetration and enhance brand recognition.

Moreover, technological advancements in the field of cardiovascular surgical devices present another avenue for growth. Innovations such as minimally invasive surgical techniques, robotic-assisted procedures, and smart monitoring systems are transforming cardiac care. Companies that focus on research and development will be well-positioned to introduce cutting-edge devices that improve patient outcomes and reduce recovery times. Collaborations with research institutions and healthcare providers can drive innovation and expedite the development of new products. As digital health technologies continue to gain traction, integrating connectivity features into cardiovascular devices can enhance monitoring and provide valuable data to healthcare providers, amplifying their attractiveness in the marketplace.

Threats

Despite the promising growth outlook for the cardiovascular surgical devices market, several threats could hinder progress. One of the primary challenges is the stringent regulatory environment governing the approval and commercialization of surgical devices. The regulatory landscape can vary significantly by region, leading to potential delays in product launches due to lengthy approval processes. Additionally, manufacturers may face challenges in complying with diverse regulatory requirements across different countries, which can escalate costs and complicate market entry strategies. To navigate these challenges, companies must invest in regulatory expertise and proactive compliance measures to ensure timely market access.

Another significant threat to the cardiovascular surgical devices market is the rapid pace of technological advancements. While innovation is a driver of growth, it can also lead to increased competition as new entrants and established players aim to capture market share with cutting-edge products. Companies may find it challenging to differentiate their offerings in a crowded marketplace, leading to pricing pressures and reduced profit margins. To mitigate this threat, organizations must focus on continuous innovation, invest in marketing strategies that effectively communicate their competitive advantages, and foster strong relationships with healthcare providers to solidify their positioning in the market.

Competitor Outlook

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• Cook Medical
• Cardinal Health
• Terumo Corporation
• Stryker Corporation
• Edwards Lifesciences Corporation
• Philips Healthcare
• St. Jude Medical (now part of Abbott)
• Zimmer Biomet
• W. L. Gore & Associates
• Hologic, Inc.
• Asahi Intecc Co., Ltd.

The competitive landscape of the cardiovascular surgical devices market is characterized by a mix of established players and emerging companies, all striving to innovate and capture market share. Major companies like Medtronic and Abbott Laboratories are at the forefront, leveraging their extensive research and development capabilities to create cutting-edge products that address the growing needs of cardiovascular patients. Medtronic, for example, is renowned for its innovative cardiac rhythm management devices and is continuously expanding its portfolio through strategic acquisitions and partnerships. Abbott Laboratories has similarly focused on diversifying its offerings, especially in the areas of stents and cardiac monitoring devices, thus positioning itself as a leader in the market.

Another key player, Boston Scientific Corporation, is recognized for its commitment to advancing technology in the cardiovascular space, particularly in the realm of interventional cardiology. Their innovative devices, including drug-eluting stents and advanced electrophysiology products, have significantly improved patient outcomes and established the company as a formidable competitor in the market. In addition, companies like Edwards Lifesciences and Stryker Corporation are making significant strides in the heart valve and cardiac assist device segments, respectively, by focusing on minimally invasive solutions that enhance patient recovery times. The emphasis on patient-centric care and improved surgical techniques is driving these companies to invest heavily in research and development, ultimately fostering continued innovation in the marketplace.

Furthermore, regional players, such as Terumo Corporation and W. L. Gore & Associates, are emerging as key competitors in specific markets, capitalizing on their understanding of local healthcare needs and regulatory landscapes. These companies often focus on niche markets, providing tailored solutions that can compete effectively with larger multinational corporations. The competitive landscape is further enhanced by the rise of start-ups focusing on digital health solutions, wearable devices, and telemedicine in cardiovascular care, showcasing the dynamic nature of this market. As the cardiovascular surgical devices landscape continues to evolve, it will be essential for all players to remain agile and innovative, ensuring they meet the demands of an increasingly sophisticated patient population.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Zimmer Biomet
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Cardinal Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Philips Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Asahi Intecc Co., Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 W. L. Gore & Associates
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Johnson & Johnson (Ethicon)
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Edwards Lifesciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 St. Jude Medical (now part of Abbott)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cardiovascular Surgical Devices and Technologies Market, By Application
    • 6.1.1 Coronary Artery Disease
    • 6.1.2 Heart Failure
    • 6.1.3 Arrhythmias
    • 6.1.4 Peripheral Artery Disease
  • 6.2 Cardiovascular Surgical Devices and Technologies Market, By Product Type
    • 6.2.1 Cardiac Ablation Devices
    • 6.2.2 Cardiopulmonary Bypass Equipment
    • 6.2.3 Cardiovascular Monitoring Devices
    • 6.2.4 Cardiac Assist Devices
    • 6.2.5 Heart Valves
  • 6.3 Cardiovascular Surgical Devices and Technologies Market, By Ingredient Type
    • 6.3.1 Stents
    • 6.3.2 Grafts
    • 6.3.3 Catheters
    • 6.3.4 Pacemakers
    • 6.3.5 Defibrillators
  • 6.4 Cardiovascular Surgical Devices and Technologies Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cardiovascular Surgical Devices and Technologies Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cardiovascular Surgical Devices and Technologies market is categorized based on

By Product Type

• Cardiac Ablation Devices
• Cardiopulmonary Bypass Equipment
• Cardiovascular Monitoring Devices
• Cardiac Assist Devices
• Heart Valves

By Application

• Coronary Artery Disease
• Heart Failure
• Arrhythmias
• Peripheral Artery Disease

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Ingredient Type

• Stents
• Grafts
• Catheters
• Pacemakers
• Defibrillators

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• Cook Medical
• Cardinal Health
• Terumo Corporation
• Stryker Corporation
• Edwards Lifesciences Corporation
• Philips Healthcare
• St. Jude Medical (now part of Abbott)
• Zimmer Biomet
• W. L. Gore & Associates
• Hologic, Inc.
• Asahi Intecc Co., Ltd.